Profile
Cenk Sumen worked as a Director at Thermo Fisher Scientific, Inc. and as a Senior Manager-Business Development at Minaris Regenerative Medicine LLC from 2014 to 2018.
He was also the Chief Scientific Officer at MaxCyte, Inc. from 2022 to 2024.
Currently, he is the Chief Technology Officer at Stemson Therapeutics, LLC.
Dr. Sumen received his undergraduate and doctorate degrees from Stanford University.
Former positions of Cenk Sumen
| Companies | Position | End |
|---|---|---|
| MAXCYTE, INC. | Chief Tech/Sci/R&D Officer | 2024-01-22 |
| THERMO FISHER SCIENTIFIC, INC. | Director/Board Member | 2018-03-31 |
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Provides cell therapy services | Corporate Officer/Principal | 2018-03-31 |
Stemson Therapeutics, LLC
Stemson Therapeutics, LLC Miscellaneous Commercial ServicesCommercial Services Develops cell therapies to grow new hair follicles | Chief Tech/Sci/R&D Officer | - |
Training of Cenk Sumen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Provides cell therapy services | Health Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Stemson Therapeutics, LLC
Stemson Therapeutics, LLC Miscellaneous Commercial ServicesCommercial Services Develops cell therapies to grow new hair follicles | Commercial Services |
- Stock Market
- Insiders
- Cenk Sumen
















